
Bafna Pharmaceuticals Ltd. Hits Lower Circuit on NSE, 18 November 2026
Updated: 18 Nov 2026 • 12:37 pm
Posted by:

On 18 November 2026, Bafna Pharmaceuticals Ltd. (BAFNAPH) hit the lower circuit on NSE at Rs 470.4, a 2% negative move from the previous close of Rs 480. The company's market cap stood at Rs 1135.5 crore. The lower circuit price for the session was Rs 470.4.
The Bafna Pharmaceuticals lower circuit came as selling pressure met the exchange-defined price band. At the time of writing the stock was locked at its lower circuit level, which makes the session worth noting for short-term market participants.
Key Takeaways
- Bafna Pharmaceuticals Ltd. (BAFNAPH) hit the lower circuit on NSE at Rs 470.4 on 18 November 2026.
- The session move was -2% against a previous close of Rs 480.
- Market capitalisation stood at Rs 1135.5 crore with a PE ratio of 98.65.
- No official company announcement or verified catalyst was confirmed at the time of writing.
- A price band is an exchange trading rule, not a view on the company or a recommendation.
Key Market Data
| Metric | Value |
|---|---|
| Stock | Bafna Pharmaceuticals Ltd. |
| Current Price / LTP | Rs 470.4 |
| Day Move | -2% |
| Previous Close | Rs 480 |
| Day Open | Rs 0 |
| Day High | Rs 480 |
| Day Low | Rs 470.4 |
| Lower Circuit Price | Rs 470.4 |
| Lower Circuit Limit | Rs 470.4 |
| Market Cap | Rs 1135.5 crore |
| Selected Exchange | NSE |
| PE Ratio | 98.65 |
All figures above are as of 18 November 2026, sourced from Univest market data for the NSE listing. Only fields present in the source for this session are shown.
Price Action and Trading Activity
Bafna Pharmaceuticals Ltd. opened at Rs 0 on NSE, compared with a previous close of Rs 480. During the session, the stock traded between Rs 470.4 and Rs 480 before touching the lower circuit price of Rs 470.4.
The absolute day change was Rs 9.6, while the percentage move was -2%. The event figures are kept to a single exchange so the numbers stay comparable.
The selected exchange matters because price bands, day range and previous-close values can differ across exchanges. This article uses NSE consistently for the event table and narrative. The stated lower circuit limit for the session was Rs 470.4, which is the level the price reached.
Why Bafna Pharmaceuticals Ltd. Hit Lower Circuit
Bafna Pharmaceuticals Ltd. hit the lower circuit after selling pressure pushed the stock to its exchange-defined price band. No official company announcement or verified external catalyst was confirmed at the time of writing, so the move should be read primarily through price action and market sentiment.
Because no verified catalyst was available, this article does not attribute the move to earnings, corporate action, sector news, or market rumours. If a confirmed announcement becomes available later, it should be added as a separate update.
Within the session the stock reached the lower circuit level of Rs 470.4.
What the Bafna Pharmaceuticals Lower Circuit Means
A lower circuit is the minimum price level a stock is allowed to reach during a trading session under the applicable exchange price band. For Bafna Pharmaceuticals Ltd., the captured lower circuit price was Rs 470.4 on 18 November 2026.
The circuit mechanism is meant to slow extreme price movement and keep trading orderly. It is a market-structure fact, not a return forecast. In this article, the lower circuit explains what happened in the session and where the price band was reached.
Bafna Pharmaceuticals Ltd. Fundamentals and Valuation
Available market data gives a fuller picture than price action alone. For Bafna Pharmaceuticals Ltd., PE ratio was 98.65, PB ratio was 11, book value was Rs 43.62, EPS was 4.87, ROE was 12.27%, ROCE was 11.87%, dividend yield was 0% and debt-to-assets ratio was 0.39, on a market cap of Rs 1135.5 crore. These are available financial indicators and should not be read as a buy, sell, or hold view.
At the reported PB ratio of 11, the market valued Bafna Pharmaceuticals Ltd. above its reported book value per share. That premium can reflect growth expectations, asset quality, or simply thin trading in a smaller counter.
For investors tracking lower circuit moves, these metrics help separate the price event from the broader financial profile. A sharp one-day move can attract attention, but valuation and return ratios still need to be reviewed separately.
Peer and Sector Context
Bafna Pharmaceuticals Ltd. belongs to the Pharmaceuticals & Drugs industry within the Healthcare sector. The peer table below uses available companies from the same sector or industry to give broader valuation context.
| Peer Company | Market Cap | PE | PB | ROE |
|---|---|---|---|---|
| Solara Active Pharma Sciences Ltd. | Rs 3213.55 crore | 86.99 | 2.24 | -0.63% |
| Advanced Enzyme Technologies Ltd. | Rs 3100.7 crore | 18.15 | 1.94 | 11.43% |
| Ind-Swift Laboratories Ltd. | Rs 2938.02 crore | 35.16 | 1.96 | 3.47% |
| Fredun Pharmaceuticals Ltd. | Rs 2694.87 crore | 50.88 | 7.78 | 16.09% |
| Hikal Ltd. | Rs 2687.34 crore | - | 2.27 | -3.97% |
A dash in the PE column means no PE ratio was carried for that company in the source data, which happens when reported earnings are negative or have not been refreshed. Those companies are left out of the average below rather than counted as zero.
Bafna Pharmaceuticals Ltd.'s PE ratio was 98.65, compared with an available peer PE average of 47.79, calculated from the 4 peer companies that had a PE on record. This comparison is a valuation reference point, not a recommendation.
Technical Snapshot
The technical snapshot adds context: RSI was 67.25, the 50-day moving average was 460.71 and the 200-day moving average was 317.78.
Worth flagging: the RSI reading sits on the opposite side of neutral to the day move and the last traded price and the 50-day average point in different directions. Indicator values in the dataset can lag the live session, so they should be checked against a live chart before being relied on.
What Readers Should Know
The main confirmed fact is that Bafna Pharmaceuticals Ltd. hit the lower circuit on NSE at Rs 470.4 on 18 November 2026, with a -2% day move.
The practical limitation after a lower-circuit session is execution. Sellers queue at the band with few buyers, so exiting at the quoted price may not be possible. The other limitation is that no official catalyst was confirmed at the time of writing.
Readers should treat lower circuit events as market updates, not standalone investment conclusions. The price band shows heavy near-term selling pressure, but follow-up analysis should consider business fundamentals, valuation, liquidity, risk, and confirmed company disclosures.
Frequently Asked Questions
Why did Bafna Pharmaceuticals Ltd. hit lower circuit on 18 November 2026?
The stock reached its lower price band after selling pressure during the session. No official company announcement or verified external catalyst was confirmed at the time of writing.
What was BAFNAPH share price on 18 November 2026?
The last traded price used in this article was Rs 470.4 on NSE. That price matched the lower circuit price captured for the event.
What was the lower circuit price for BAFNAPH?
The lower circuit price was Rs 470.4. The stated exchange lower circuit limit was Rs 470.4. The event numbers in this article are aligned to NSE.
What is Bafna Pharmaceuticals Ltd.'s market cap and PE ratio?
Bafna Pharmaceuticals Ltd.'s market cap was Rs 1135.5 crore. PE ratio was 98.65.
Which exchange and data source were used?
The selected exchange was NSE. The article uses Univest market data available at the time of generation, captured on 18 November 2026.
Does hitting a lower circuit mean Bafna Pharmaceuticals Ltd. is a buy or a sell?
No. A circuit is an exchange price-band rule that caps how far a stock can move in a single session. It carries no view on valuation or business quality and is not a recommendation. Any decision should rest on fundamentals, valuation, liquidity and your own risk tolerance.
Can you buy or sell Bafna Pharmaceuticals Ltd. shares when the stock is at the lower circuit?
It is usually difficult. At the lower circuit, sell orders queue up with few buyers, so exiting at the quoted price may not be possible. Orders can stay unfilled until buying interest returns.
What happens the next trading session after a lower circuit?
There is no fixed outcome. The band resets each session, so the stock can open freely, hit the same band again, or reverse. The exchange can also revise the applicable band width. The useful signals to watch are whether the company files any disclosure explaining the move.
What is the lower circuit limit set at for Indian stocks?
Exchange price bands are commonly set at 2%, 5%, 10% or 20% depending on the security, and the applicable band can be revised by the exchange. For Bafna Pharmaceuticals Ltd. the stated limit was Rs 470.4. For this session, Bafna Pharmaceuticals Ltd. moved -2%.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.
Recent Articles

Cummins India Share Price Slips to Rs 4,005 Near Its 52-Week Low: Margins Squeezed by Commodity Costs While Price Hikes Take a Quarter to Flow Through
18 November 2026

V2 Retail Share Price Plunges 15% to a 52-Week Low of Rs 122.73 Then Rebounds to Close at Rs 141.61: What We Know, What We Do Not and the Numbers to Watch
18 November 2026

Infosys Share Price Falls to Rs 1,108.80, Down 25.4% in a Year: How India's IT Bellwether Lost a Quarter of Its Value and What Investors Should Check Next
18 November 2026

Nifty Bank 62,000: Index Closes at 62,038.65 After a Record 62,442.20, Up 24% From Its April Low as SBI Surges While HDFC Bank and Axis Bank Lag
18 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Cummins India Share Price Slips to Rs 4,005 Near Its 52-Week Low: Margins Squeezed by Commodity Costs While Price Hikes Take a Quarter to Flow Through
V2 Retail Share Price Plunges 15% to a 52-Week Low of Rs 122.73 Then Rebounds to Close at Rs 141.61: What We Know, What We Do Not and the Numbers to Watch
Infosys Share Price Falls to Rs 1,108.80, Down 25.4% in a Year: How India's IT Bellwether Lost a Quarter of Its Value and What Investors Should Check Next
Nifty Bank 62,000: Index Closes at 62,038.65 After a Record 62,442.20, Up 24% From Its April Low as SBI Surges While HDFC Bank and Axis Bank Lag
Mahanadi Coalfields IPO Opens 19 November: Rs 129 to Rs 136 Price Band, Rs 8,981 Crore Offer for Sale and a Coal India Unit Valued at About 8.4 Times Earnings

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





